NPS-P156

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNPS-P156
Drug Alias NameNMDA receptor agonist (NPS Pharmaceuticals)D-serine analog (NPS Pharmaceuticals)NPSP-156NPS-P156
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor agonistsCNS modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeuralgiaEpilepsyCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNps Pharmaceuticals, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNps Pharmaceuticals, Inc
Active IndicationsN/A
Inactive IndicationsNeuralgiaEpilepsyCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A